Shaker Investments LLC OH Invests $559,000 in Doximity, Inc. (NASDAQ:DOCS)

Shaker Investments LLC OH acquired a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 10,470 shares of the company's stock, valued at approximately $559,000.

A number of other hedge funds have also recently modified their holdings of the business. UMB Bank n.a. increased its position in Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after buying an additional 235 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Doximity by 20.6% during the fourth quarter. GAMMA Investing LLC now owns 1,735 shares of the company's stock valued at $93,000 after acquiring an additional 296 shares in the last quarter. MetLife Investment Management LLC raised its position in shares of Doximity by 0.6% in the 3rd quarter. MetLife Investment Management LLC now owns 65,064 shares of the company's stock worth $2,835,000 after purchasing an additional 363 shares during the last quarter. State of Alaska Department of Revenue grew its position in Doximity by 2.6% during the 4th quarter. State of Alaska Department of Revenue now owns 14,610 shares of the company's stock valued at $780,000 after purchasing an additional 370 shares during the last quarter. Finally, First Horizon Advisors Inc. raised its holdings in Doximity by 22.5% in the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company's stock worth $91,000 after buying an additional 384 shares during the last quarter. Institutional investors own 87.19% of the company's stock.

Analysts Set New Price Targets

A number of research firms have recently commented on DOCS. Leerink Partnrs upgraded shares of Doximity from a "hold" rating to a "strong-buy" rating in a report on Friday, February 7th. Piper Sandler upgraded Doximity from a "neutral" rating to an "overweight" rating and increased their target price for the company from $31.00 to $78.00 in a research note on Friday, February 7th. Morgan Stanley upgraded Doximity from an "underweight" rating to an "equal weight" rating and boosted their price target for the stock from $33.00 to $53.00 in a research note on Thursday, November 14th. Canaccord Genuity Group increased their price objective on Doximity from $60.00 to $71.00 and gave the company a "hold" rating in a research report on Friday, February 7th. Finally, Raymond James restated an "outperform" rating and set a $83.00 price target (up from $65.00) on shares of Doximity in a research note on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $64.22.

Doximity Trading Up 0.3 %

Shares of DOCS stock traded up $0.21 during trading hours on Friday, hitting $77.20. The company's stock had a trading volume of 1,845,092 shares, compared to its average volume of 2,353,556. The company has a 50 day moving average of $57.46 and a 200 day moving average of $47.03. The stock has a market cap of $14.41 billion, a PE ratio of 77.35, a price-to-earnings-growth ratio of 4.61 and a beta of 1.39. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21.

Insiders Place Their Bets

In related news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares of the company's stock, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 37.40% of the company's stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.